🔗 Share this article

Grammy-winning R&B singer D’Angelo died on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The shining star of our household has dimmed his light for us in the present world,” his relatives confirmed. “After a lengthy and brave struggle with cancer, we are heartbroken to announce that Michael D’Angelo Archer, recognized by his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his pioneering neo-soul sound and collaborations with high-profile artists.

He released his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record achieved No. 4 on Billboard’s Top R&B Albums chart, earned platinum status soon after, and received multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his artistic journey into the stratosphere. The album premiered at the top spot on each of the R&B charts and the main album chart. He received two Grammy Awards: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a hesitant one, in the cultural zeitgeist. The intimate portrayal showed the singer, notably stripped down to his midsection, singing straight into the lens.

D’Angelo stepped back from the public eye after putting out Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a serious car crash that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with another top chart entry on the soul music rankings and a Grammy for Best R&B Album.

Again, in his own enigmatic way, D’Angelo made only a few public appearances in the subsequent period.

The singer was scheduled as a top act for the 2025 Roots Picnic festival, but his performance was canceled, citing an “unexpected health issue.”

Although details are sparse about D’Angelo’s well-being in the weeks leading up to his passing, he had reportedly been in the hospital for an extended period and in hospice for two weeks.

D’Angelo’s passing is a clear example of the harmful impact of pancreatic malignancy, one of the most deadly and least preventable types of the disease, on a brilliant talent whose life was cut short.

“We are saddened that he can only provide dear memories with his loved ones, but we are eternally grateful for the heritage of deeply emotional music he has left us,” his family expressed.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic cancer impacts the pancreas, a small organ that generates the hormone insulin and plays an essential role in digestion, among other functions. The size and location of the organ in the human system make it more difficult to detect cancer.

Although pancreatic cancer accounts for only about 3% of cancer diagnoses annually in the United States, it is causes 7% of malignancy fatalities.

Nearly seventy thousand individuals will be found to have this condition and about 52,000 will die of the disease in the year 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have limited and ineffective therapies, and a smaller window to make a meaningful impact on the lives of people,” said a medical oncologist.

Since this disease rarely causes initial signs, it’s frequently identified only once the disease is advanced. Although a patient has indicators they are often vague and may be confused with a several common illnesses.

“As of yet, there is no effective method to identify this malignancy in the initial phases, apart from paying attention to physical changes and consulting your physician if there are unfamiliar signs,” said a medical director.

Frequent indicators of this disease include:

• discomfort in the stomach or back
• weight loss
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s demise is an exception, as pancreatic cancer is most common in individuals in the 65 to 75 range. However, numerous malignancies, such as this type, have become more common in younger people.

“Pancreatic cancer identified before the age of 50 is deemed rare, yet concerningly, doctors are beginning to see a rising count of younger patients affected by this disease,” said a specialist.

Family History Affects Cancer Risk

Without reliable detection methods for pancreatic cancer, experts emphasized the importance of understanding your family’s cancer history. Certain contributing elements, such as smoking and excess weight also play a role in the onset of pancreatic cancer.

Black individuals have the highest incidence of this malignancy in the U.S. and are most likely to be diagnosed with untreatable disease.

“The first step toward reducing one’s chance of pancreatic cancer is assessing individual susceptibility. People should examine their family history, genetic background, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or overweight that may increase their vulnerability,” said a specialist.

Inherited genetic risk factors are linked to as much as 10% of all this malignancy instances. If someone in your family has had this disease, you may want to consider DNA analysis.

“For individuals with a relative’s background of pancreatic cancer or those having high risk genetic mutations, screening may involve advanced imaging such as MRI scans or internal ultrasound to find early changes in the pancreas,” he clarified.

For those looking to reduce their risk, lifestyle changes may have an effect. The most effective step you can take to reduce your susceptibility of this disease is to stop tobacco use, and if you are a non-smoker, avoid exposure altogether.

Excessive drinking is associated with pancreatitis, a risk factor for this malignancy, so reducing or abstaining from alcohol may help reduce your risk.

Controlling your body mass or shedding pounds may also help decrease your susceptibility. People with excess weight are 20% more likely to develop this disease. This malignancy also is more frequent in those with blood sugar issues, and reducing weight can also lower the chance of type 2 diabetes.

In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and newer mixed drug treatments. There are emerging precision medicines that are already making an impact,” said a specialist.

For numerous individuals, however, awareness about this rare but {dev